PATENT CLAIM ANALYSIS

Application Number: 15860200
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["424", "139100"]

Abstract:
The present invention provides isolated human or humanized antibodies or antigen-binding fragments thereof which specifically bind to Growth and Differentiation Factor-8 (GDF8) and block GDF8 activity. The antibodies and antibody fragments of the present invention may be used in therapeutic methods for treating conditions or disorders which are ameliorated or improved by inhibition of GDF8.

Claim (Index 34):
The isolated antibody or antigen-binding fragment of  claim 33 , wherein the chimeric GDF8/TGF\u03b21 construct comprises the amino acid sequence of SEQ ID NO:352.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 86.0
- Lexical Diversity: 1.34091
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14974147', '13115170', '14462085', '15637867', '14447444']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.812713682428625
- 35 USC 102 Novelty (BERT): 0.6694012664800236
- Combined Prediction Score: 0.7983824408337648
- Mean Citation Score: 629.0445040000002
- Max Citation Score: 750.4044
- Similarity Product: 615.5724606924534

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test